
Management of Venous Thromboembolic Disease with Dr. Lisa Moores
Curbside Consults
00:00
Doa vs Low Molecular Weight Hepren in Patience With Malignancy?
It sounds like ivy infractionated heprin for mister c for now, until we figure out which way he's going to go if he becomes more unstable. One of the additional new things we did, and this up date of the guide lines, was specifically separate out cancer associated thrombosis from hulmonarambolism. In patience without a malignancy, we've always made comments on those patients, but we did not approach them as a separate pico question.
Transcript
Play full episode